Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Knowledge Gaps in the Clinical and Epidemiological Characteristics of RSVRelease Date:Education Vaccines USA Rapid Education on COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA Real World Evidence for CDK 4/6 inhibitors in Shared Clinical Decision MakingRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA 2022/2023 Global COVID-19 ASPIRERelease Date:Research Hospital All Engaging the Patient Community in Research and Publications (USA, Canada, Europe)Education Hospital All Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel DiseaseQuality Improvement Inflammation & Immunology Japan Optimizing Canadian Telehealth Use for Women’s HealthRelease Date:Quality Improvement Internal Medicine Canada Gene Therapy Site-Preparedness Competitive Grant ProgramRelease Date:Partner: International Pharmaceutical Federation (FIP)Quality Improvement Rare Disease All Call for Independent Quality Improvement Grant Applications Oncology – Prostate CancerQuality Improvement Oncology USA Global Hemophilia Grant - Equity in Therapeutic Patient EducationRelease Date:Review Process: Expert Review PanelEducation Rare Disease All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All